TipRanks
1st Group Ltd. (AU:VFX)
ASX:VFX
Australian Market
Want to see AU:VFX full AI Analyst Report?

1st Group Ltd. (VFX) AI Stock Analysis

3 Followers

Top Page

AU:VFX

1st Group Ltd.

(Sydney:VFX)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - Gpt-5.6Sol)
Rating:41Neutral
Price Target:
AU$0.04
▼(-62.00% Downside)
Action:Reiterated
Date:10/01/26
The score is primarily held down by weak financial fundamentals (negative equity and ongoing cash burn) despite some improvement in the net loss. Technicals are also bearish with the price below key moving averages, though oversold readings modestly offset this. Valuation provides limited support because losses drive a negative P/E and there is no dividend yield.
Positive Factors
Improving Net Loss
The sharp reduction in net loss indicates that management has improved the earnings trajectory, whether through cost actions or other factors identified in the results. If maintained, this progress could reduce funding needs and provide a foundation for eventual profitability, although the turnaround remains incomplete.
Negative Factors
Negative Shareholders’ Equity
Persistently negative equity signals a stressed capital structure and materially limits financial flexibility. It can make refinancing more difficult, reduce the company’s ability to absorb setbacks, and constrain investment capacity until retained losses are reversed and the balance sheet is rebuilt through sustained profitability or new capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Net Loss
The sharp reduction in net loss indicates that management has improved the earnings trajectory, whether through cost actions or other factors identified in the results. If maintained, this progress could reduce funding needs and provide a foundation for eventual profitability, although the turnaround remains incomplete.
Read all positive factors

1st Group Ltd. (VFX) vs. iShares MSCI Australia ETF (EWA)

1st Group Ltd. Business Overview & Revenue Model

Company Description
Operating in Australia, Visionflex Group Limited and its associated companies specialize in providing cutting-edge healthcare, telehealth, and remote diagnostic services. The company's portfolio features virtual healthcare systems and specialized ...

1st Group Ltd. Financial Statement Overview

Summary
Financial strength remains very weak: negative shareholders’ equity, ongoing negative operating cash flow and consistently negative free cash flow point to continued funding dependence and elevated solvency/liquidity risk. The key positive is a major improvement in net loss in 2026 versus 2025, but revenue fell (~7%) and profitability is still negative, so the turnaround is not yet proven.
Income Statement
18
Very Negative
Balance Sheet
9
Very Negative
Cash Flow
12
Very Negative
BreakdownJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue4.14M4.19M6.65M4.47M4.83M
Gross Profit-887.14K-2.42M3.94M3.41M4.83M
EBITDA-2.06M-3.37M-1.32M-3.56M-6.44M
Net Income-57.80K-3.19M-1.83M-3.66M-6.82M
Balance Sheet
Total Assets3.09M3.39M2.88M4.09M4.27M
Cash, Cash Equivalents and Short-Term Investments1.62M1.89M1.16M1.44M2.01M
Total Debt577.99K2.47M13.65M12.11M4.65M
Total Liabilities3.11M5.22M19.76M18.73M8.16M
Stockholders Equity-14.69K-1.82M-8.11M-6.74M-3.89M
Cash Flow
Free Cash Flow-1.27M-3.19M-1.38M-3.68M-2.82M
Operating Cash Flow-1.26M-3.16M0.000.000.00
Investing Cash Flow-15.56K-29.51K276.80K720.13K-21.84K
Financing Cash Flow1.02M3.92M798.81K2.36M4.59M

1st Group Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.10
Price Trends
50DMA
0.04
Negative
100DMA
0.05
Negative
200DMA
0.06
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
27.94
Positive
STOCH
17.65
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:VFX, the sentiment is Negative. The current price of 0.1 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and above the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 27.94 is Positive, neither overbought nor oversold. The STOCH value of 17.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:VFX.

1st Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
AU$148.48M64.712.53%―26.61%41.67%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
AU$14.31M-5.88-416.53%―113.42%29.17%
48
Neutral
AU$109.10M-6.38-203.69%―-1.53%28.29%
45
Neutral
AU$21.26M-1.14-58.13%―2.08%-195.31%
41
Neutral
AU$3.47M-200.00-84.46%―-10.07%99.60%
40
Underperform
AU$16.32M-1.80-1688.04%―11.45%0.69%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:VFX
1st Group Ltd.
0.04
-0.04
-47.37%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.13
-0.07
-33.33%
AU:BMT
Beamtree Holdings Ltd
0.07
-0.15
-67.27%
AU:ALC
Alcidion Group Limited
0.11
0.02
22.22%
AU:ICR
InteliCare Holdings Limited
0.02
0.00
0.00%
AU:PCK
PainChek Ltd
0.08
-0.40
-83.75%

1st Group Ltd. Corporate Events

Visionflex trims costs as aged-care churn hits recurring revenue
Oct 30, 2026
Visionflex Group reported unaudited Q1 FY27 revenue of $0.9 million, a 3% rise on the prior year, with operating and administration payments reduced by 12% to $1.8 million, improving net operating cash outflow to $0.9 million. Customer cash receip...
Visionflex Posts Quarterly Cash Outflow but Maintains Cash Buffer
Oct 30, 2026
Visionflex Group Limited reported customer receipts of A$893,000 for the quarter ended 30 September 2026, reflecting ongoing demand for its telehealth and digital health solutions. Operating expenditure was driven largely by product manufacturing,...
Visionflex sets November AGM as it builds out virtual healthcare platform
Oct 19, 2026
Visionflex Group Limited, a specialist in virtual healthcare technology, delivers integrated hardware and software systems that connect healthcare teams to deliver real-time, collaborative care across metropolitan and community settings. The compa...
Visionflex Group Seeks ASX Quotation for Additional Ordinary Shares
Sep 30, 2026
Visionflex Group Limited has lodged an application with the ASX for quotation of 95,556 ordinary fully paid shares under its existing issuer code VFX. The securities are to be quoted from September 30, 2026, expanding the company’s listed sh...
Visionflex hires related-party consultants to design exemplar mobile clinic
Sep 18, 2026
Visionflex Group has engaged two related-party consultancies, Yotchi Pty Limited and Sixth Street Pty Ltd, to design and cost an exemplar mobile clinic vehicle as part of an investment evaluation for its virtual healthcare offerings. The fixed-fee...
Visionflex seeks ASX quotation for new share issue
Sep 18, 2026
Visionflex Group Limited has applied for the quotation of 51,350 ordinary fully paid shares on the Australian Securities Exchange, with the new securities issued on 17 September 2026. The application follows the exercise or conversion of options o...
Visionflex files Appendix 4G and updates corporate governance statement
Aug 28, 2026
Visionflex Group Limited has lodged its Appendix 4G and updated Corporate Governance Statement for the financial year ended 30 June 2026, in line with ASX listing rule requirements. The governance statement, approved by the board and made availabl...
Visionflex Narrows Losses and Builds Recurring Revenue Despite FY26 Sales Dip
Aug 28, 2026
Visionflex Group reported FY26 revenue of $4.2 million, down 10% due to customer deferrals of hardware deliveries into FY27, but significantly improved profitability metrics, including an 86% gross margin and an 84% reduction in statutory loss bef...
Visionflex Group Tables 2026 Annual Report for Investors
Aug 28, 2026
Visionflex Group Limited has released its 2026 annual report, which compiles key governance, financial, and operational disclosures for investors. The report includes chair and CEO commentary, detailed directors’ and remuneration reports, pr...
Visionflex slashes annual loss but auditor flags going-concern risks
Aug 28, 2026
Visionflex Group Limited reported a 10% decline in revenue to $4.18 million for the year ended 30 June 2026, but drastically reduced its net loss to $54,772 from $3.09 million a year earlier. The company did not declare dividends and its net tangi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 01, 2026